MLYS EPS Estimates
Mineralys Therapeutics, Inc.
$20.30
-$1.34(-6.19%)
39
Overall
55
Value
27
Tech
36
Quality
Market Cap
$1.79B
Volume
1.18M
52W Range
$21.46 - $47.65
Target Price
$48.50
MLYS EPS estimates: the consensus estimate for Mineralys Therapeutics, Inc.'s current fiscal year is -$4.45 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MLYS EPS Estimates
- EPS estimate, current quarter
- $-0.53
- EPS estimate, next quarter
- $-0.60
- EPS estimate, current year
- $-4.45
- EPS estimate, next year
- $-1.92
- EPS growth, 3-year
- -7.27%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.29 |
| 2024 | $-3.66 |
| 2023 | $-1.99 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $20.30 | -6.2% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW